Inflximab and hepatic steatosis Patient Reports February 06, 2012

Inflximab Side Effects Report #5284855-7
Inflximab side effect was reported by a Health Professional from UNITED KINGDOM on Mar 21, 2007. Female patient, weighting 167.6 lb, was diagnosed with rheumatoid arthritis  and was treated with Inflximab. After drug was administered, patient experienced the following side effects: hepatic steatosis, liver function test abnormal. Inflximab dosage: unknown. During the same period patient was treated with METHOTREXATE, PREDNISOLONE, ALENDRONATE, ETODOLAC, FOLIC ACID, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.